GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$69.85 USD
-1.47 (-2.06%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $70.07 +0.22 (0.31%) 7:58 PM ET
1-Strong Buy of 5 1
B Value F Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, GE HealthCare Technologies Inc. has a PEG ratio of 2.06 compared to the Medical - Products industry's PEG ratio of 2.14.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
GEHC 69.85 -1.47(-2.06%)
Will GEHC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GEHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GEHC
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
GEHC vs. BSX: Which Stock Is the Better Value Option?
GEHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics
GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates
Other News for GEHC
GEHC: Morgan Stanley Maintains Equal-Weight, Lowers Price Target | GEHC Stock News
GEHC: Citigroup Maintains Buy Rating, Raises Price Target to $93 | GEHC Stock News
GE HealthCare price target raised by $6 at Citi, here's why
GEHC: Citi Boosts Price Target Amid Robust Pipeline
GE HealthCare price target raised by $4 at Citi, here's why